CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-19 | Dissanaike Sharmila Director | Grant or award | +13,948 | 69,230 | ||
| 2024-01-19 | Dissanaike Sharmila Director | Grant or award · Stock Option (Right to Buy) | +83,685 | 83,685 | ||
| 2024-01-19 | Peraza Lisa VP, Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +41,078 | 41,078 | ||
| 2024-01-19 | Peraza Lisa VP, Chief Accounting Officer | Grant or award · Restricted Stock Units | +6,846 | 6,846 | ||
| 2024-01-19 | Forbes William P EVP, Chief Development Officer | Grant or award · Employee Stock Option (Right to Buy) | +371,935 | 371,935 | ||
| 2024-01-19 | Forbes William P EVP, Chief Development Officer | Grant or award · Restricted Stock Units | +61,989 | 61,989 | ||
| 2024-01-19 | Duarte Ira EVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +371,935 | 371,935 | ||
| 2024-01-19 | Duarte Ira EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +61,989 | 61,989 | ||
| 2024-01-19 | Collard Craig A Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +1,324,502 | 1,324,502 | ||
| 2024-01-19 | Collard Craig A Chief Executive Officer | Grant or award · Restricted Stock Units | +220,750 | 220,750 | ||
| 2024-01-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +552 | 55,374 | ||
| 2024-01-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +1,289 | 56,663 | ||
| 2024-01-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −756 | $2.15 | $2K | 55,907 |
| 2024-01-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −552 | 1,656 | ||
| 2024-01-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −1,289 | 6,675 | ||
| 2023-11-17 | Forbes William P EVP, Chief Development Officer | Purchase | +25,000 | $1.09 | $27K | 79,000 |
| 2023-11-16 | Forbes William P EVP, Chief Development Officer | Purchase | +50,000 | $0.94 | $47K | 54,000 |
| 2023-11-16 | Collard Craig A Chief Executive Officer | Purchase | +150,000 | $0.92 | $138K | 186,496 |
| 2023-11-16 | Duarte Ira EVP, Chief Financial Officer | Purchase | +85,000 | $0.89 | $76K | 85,000 |
| 2023-10-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +552 | 53,750 |
Page 13 of 28 · 557 trades